136 related articles for article (PubMed ID: 17046757)
1. Switching feedback mechanisms realize the dual role of MCIP in the regulation of calcineurin activity.
Shin SY; Choo SM; Kim D; Baek SJ; Wolkenhauer O; Cho KH
FEBS Lett; 2006 Oct; 580(25):5965-73. PubMed ID: 17046757
[TBL] [Abstract][Full Text] [Related]
2. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
3. System-level investigation into the regulatory mechanism of the calcineurin/NFAT signaling pathway.
Shin SY; Yang JM; Choo SM; Kwon KS; Cho KH
Cell Signal; 2008 Jun; 20(6):1117-24. PubMed ID: 18325738
[TBL] [Abstract][Full Text] [Related]
4. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
[TBL] [Abstract][Full Text] [Related]
5. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
[TBL] [Abstract][Full Text] [Related]
6. Modulatory calcineurin-interacting proteins 1 and 2 function as calcineurin facilitators in vivo.
Sanna B; Brandt EB; Kaiser RA; Pfluger P; Witt SA; Kimball TR; van Rooij E; De Windt LJ; Rothenberg ME; Tschop MH; Benoit SC; Molkentin JD
Proc Natl Acad Sci U S A; 2006 May; 103(19):7327-32. PubMed ID: 16648267
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
[TBL] [Abstract][Full Text] [Related]
8. [Thyroid hormones and muscle phenotype: involvement of new signaling pathways].
Bigard AX; Koulmann N; Bahi L; Sanchez H; Ventura-Clapier R
J Soc Biol; 2008; 202(2):93-100. PubMed ID: 18547505
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.
Grebe C; Klingebiel TM; Grau SP; Toischer K; Didié M; Jacobshagen C; Dullin C; Hasenfuss G; Seidler T
Cardiovasc Res; 2011 Jun; 90(3):521-8. PubMed ID: 21273244
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Down Syndrome Critical Region 1 expression by Nuclear Factor of Activated T cells in megakaryocytes.
Kyttälä S; Habermann I; Minami T; Ehninger G; Kiani A
Br J Haematol; 2009 Feb; 144(3):395-408. PubMed ID: 19036088
[TBL] [Abstract][Full Text] [Related]
11. Annexin A7 deficiency potentiates cardiac NFAT activity promoting hypertrophic signaling.
Voelkl J; Alesutan I; Pakladok T; Viereck R; Feger M; Mia S; Schönberger T; Noegel AA; Gawaz M; Lang F
Biochem Biophys Res Commun; 2014 Feb; 445(1):244-9. PubMed ID: 24508799
[TBL] [Abstract][Full Text] [Related]
12. Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway.
Rana OR; Saygili E; Meyer C; Gemein C; Krüttgen A; Andrzejewski MG; Ludwig A; Schotten U; Schwinger RH; Weber C; Weis J; Mischke K; Rassaf T; Kelm M; Schauerte P
J Mol Cell Cardiol; 2009 Apr; 46(4):568-78. PubMed ID: 19150448
[TBL] [Abstract][Full Text] [Related]
13. Dosage-dependent transcriptional regulation by the calcineurin/NFAT signaling in developing myocardium transition.
Yang XY; Yang TT; Schubert W; Factor SM; Chow CW
Dev Biol; 2007 Mar; 303(2):825-37. PubMed ID: 17198697
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of the calcipressin 1 motif that suppresses calcineurin-mediated NFAT-dependent cytokine gene expression in human T cells.
Aubareda A; Mulero MC; Pérez-Riba M
Cell Signal; 2006 Sep; 18(9):1430-8. PubMed ID: 16406492
[TBL] [Abstract][Full Text] [Related]
15. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
16. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
[TBL] [Abstract][Full Text] [Related]
17. Low UVA doses activate the transcription factor NFAT in human fibroblasts by a calcium-calcineurin pathway.
Mazière C; Morlière P; Louandre C; Conte MA; Gomilla C; Santus R; Antonicelli F; Hornebeck W; Mazière JC
Free Radic Biol Med; 2005 Dec; 39(12):1629-37. PubMed ID: 16298688
[TBL] [Abstract][Full Text] [Related]
18. Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy.
Vega RB; Rothermel BA; Weinheimer CJ; Kovacs A; Naseem RH; Bassel-Duby R; Williams RS; Olson EN
Proc Natl Acad Sci U S A; 2003 Jan; 100(2):669-74. PubMed ID: 12515860
[TBL] [Abstract][Full Text] [Related]
19. Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway.
Meissner JD; Umeda PK; Chang KC; Gros G; Scheibe RJ
J Cell Physiol; 2007 Apr; 211(1):138-48. PubMed ID: 17111365
[TBL] [Abstract][Full Text] [Related]
20. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy.
Wilkins BJ; Molkentin JD
Biochem Biophys Res Commun; 2004 Oct; 322(4):1178-91. PubMed ID: 15336966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
